ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS
Clinical trials for ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug begins first human tests
Disease control Recruiting nowThis is the first study in people to test a new drug called HRS-7172. It aims to find a safe dose and see how the body processes the drug in 120 adults with advanced solid tumors that have specific genetic changes (RAS mutations or amplifications). The main goal is to check for s…
Matched conditions: ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 05:26 UTC
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in people testing a new drug called HRS-2329 for advanced solid tumors that have specific genetic changes called RAS mutations or amplifications. The main goal is to find a safe dose and understand how the drug moves through the body. It will enroll about …
Matched conditions: ADVANCED SOLID TUMORS HARBORING RAS MUTATIONS OR AMPLIFICATIONS
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC